Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Mallinckrodt
Boehringer Ingelheim
Dow
Moodys

Last Updated: May 28, 2022

CLINICAL TRIALS PROFILE FOR AMLODIPINE BESYLATE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Amlodipine Besylate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00136851 ↗ Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension Completed Novartis Pharmaceuticals Phase 4 2004-12-01 This trial is designed to study the efficacy of an amlodipine besylate/benazepril treatment regimen versus an amlodipine treatment regimen in the treatment of severe hypertension.
NCT00289406 ↗ Efficacy and Safety Study of S-Amlodipine Gentisate Compared to Amlodipine Besylate to Treat Mild-to-Moderate Hypertension Completed SK Chemicals Co., Ltd. Phase 3 2006-01-01 The goal of this study is to compare the antihypertensive effect and tolerability of S-amlodipine gentisate with those of amlodipine besylate in patients with mild to moderate hypertension.
NCT00289406 ↗ Efficacy and Safety Study of S-Amlodipine Gentisate Compared to Amlodipine Besylate to Treat Mild-to-Moderate Hypertension Completed SK Chemicals Co.,Ltd. Phase 3 2006-01-01 The goal of this study is to compare the antihypertensive effect and tolerability of S-amlodipine gentisate with those of amlodipine besylate in patients with mild to moderate hypertension.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Amlodipine Besylate

Condition Name

Condition Name for Amlodipine Besylate
Intervention Trials
Hypertension 20
Healthy 17
Essential Hypertension 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Amlodipine Besylate
Intervention Trials
Hypertension 28
Essential Hypertension 12
Malnutrition 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Amlodipine Besylate

Trials by Country

Trials by Country for Amlodipine Besylate
Location Trials
United States 101
China 23
Korea, Republic of 20
United Kingdom 9
India 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Amlodipine Besylate
Location Trials
Texas 6
Florida 5
Missouri 4
California 4
North Carolina 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Amlodipine Besylate

Clinical Trial Phase

Clinical Trial Phase for Amlodipine Besylate
Clinical Trial Phase Trials
Phase 4 15
Phase 3 11
Phase 2 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Amlodipine Besylate
Clinical Trial Phase Trials
Completed 41
Unknown status 8
Recruiting 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Amlodipine Besylate

Sponsor Name

Sponsor Name for Amlodipine Besylate
Sponsor Trials
CJ HealthCare Corporation 9
HK inno.N Corporation 9
Dr. Reddy's Laboratories Limited 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Amlodipine Besylate
Sponsor Trials
Industry 73
Other 13
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
AstraZeneca
Harvard Business School
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.